Morgan Stanley analyst Eric Serotta lowered the firm’s price target on Philip Morris (PM) to $175 from $182 and keeps an Overweight rating on the shares following a Q3 EPS beat driven by shipment timing and lowered FY25 operating income guidance on higher U.S. Zyn investment. While the firm doesn’t expect Q3 results to allay market concerns about soft Zyn trends and promotions, the firm sees “substantial” and above-consensus and above what’s priced-in growth ahead, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PM:
- Optimistic Outlook for Philip Morris: Buy Rating Despite ZYN Growth Overestimations
- Philip Morris price target lowered to $180 from $186 at Stifel
- Philip Morris selloff after Q3 results ‘overdone,’ says Goldman Sachs
- Philip Morris International’s Strong Q3 2025 Performance
- Philip Morris International’s Earnings Call Highlights Robust Growth